These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 26732686

  • 41. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.
    Tuunanen H, Engblom E, Naum A, Någren K, Hesse B, Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J.
    Circulation; 2006 Nov 14; 114(20):2130-7. PubMed ID: 17088453
    [Abstract] [Full Text] [Related]

  • 42. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.
    Dávila-Román VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, Kelly DP, Gropler RJ.
    J Am Coll Cardiol; 2002 Jul 17; 40(2):271-7. PubMed ID: 12106931
    [Abstract] [Full Text] [Related]

  • 43. High rates of residual fatty acid oxidation during mild ischemia decrease cardiac work and efficiency.
    Folmes CD, Sowah D, Clanachan AS, Lopaschuk GD.
    J Mol Cell Cardiol; 2009 Jul 17; 47(1):142-8. PubMed ID: 19303418
    [Abstract] [Full Text] [Related]

  • 44. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.
    Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C, Gastaldelli A, Ciociaro D, Pellegrini P, Testa R, Menichetti L, L'Abbate A, Stanley WC, Recchia FA.
    Am J Physiol Heart Circ Physiol; 2007 Dec 17; 293(6):H3270-8. PubMed ID: 17921325
    [Abstract] [Full Text] [Related]

  • 45. Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans.
    Peterson LR, Saeed IM, McGill JB, Herrero P, Schechtman KB, Gunawardena R, Recklein CL, Coggan AR, DeMoss AJ, Dence CS, Gropler RJ.
    Obesity (Silver Spring); 2012 Apr 17; 20(4):802-10. PubMed ID: 21818149
    [Abstract] [Full Text] [Related]

  • 46. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects.
    Succurro E, Vizza P, Cicone F, Cassano V, Massimino M, Giofrè F, Fiorentino TV, Perticone M, Sciacqua A, Guzzi PH, Veltri P, Andreozzi F, Cascini GL, Sesti G.
    Cardiovasc Diabetol; 2024 Apr 26; 23(1):144. PubMed ID: 38671460
    [Abstract] [Full Text] [Related]

  • 47. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
    Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E.
    Am J Physiol Endocrinol Metab; 2007 May 26; 292(5):E1288-94. PubMed ID: 17213470
    [Abstract] [Full Text] [Related]

  • 48. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance.
    McGill JB, Peterson LR, Herrero P, Saeed IM, Recklein C, Coggan AR, Demoss AJ, Schechtman KB, Dence CS, Gropler RJ.
    J Nucl Cardiol; 2011 May 26; 18(3):421-9; quiz 432-3. PubMed ID: 21516378
    [Abstract] [Full Text] [Related]

  • 49. Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 Diabetes.
    Bouchouirab FZ, Fortin M, Noll C, Dubé J, Carpentier AC.
    Can J Diabetes; 2018 Aug 26; 42(4):382-388.e1. PubMed ID: 29129455
    [Abstract] [Full Text] [Related]

  • 50. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.
    Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC.
    Am J Physiol Heart Circ Physiol; 2005 May 26; 288(5):H2102-10. PubMed ID: 15615844
    [Abstract] [Full Text] [Related]

  • 51. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
    Ng CK, Soufer R, McNulty PH.
    J Nucl Med; 1998 Mar 26; 39(3):379-83. PubMed ID: 9529278
    [Abstract] [Full Text] [Related]

  • 52. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
    Ohtake T, Yokoyama I, Watanabe T, Momose T, Serezawa T, Nishikawa J, Sasaki Y.
    J Nucl Med; 1995 Mar 26; 36(3):456-63. PubMed ID: 7884509
    [Abstract] [Full Text] [Related]

  • 53. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
    Bøtker HE, Böttcher M, Schmitz O, Gee A, Hansen SB, Cold GE, Nielsen TT, Gjedde A.
    J Nucl Cardiol; 1997 Mar 26; 4(2 Pt 1):125-32. PubMed ID: 9115064
    [Abstract] [Full Text] [Related]

  • 54. Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.
    Hannukainen JC, Lautamäki R, Mari A, Pärkkä JP, Bucci M, Guzzardi MA, Kajander S, Tuokkola T, Knuuti J, Iozzo P.
    J Clin Endocrinol Metab; 2016 Jul 26; 101(7):2701-10. PubMed ID: 27045985
    [Abstract] [Full Text] [Related]

  • 55. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
    Tuunanen H, Kuusisto J, Toikka J, Jääskeläinen P, Marjamäki P, Peuhkurinen K, Viljanen T, Sipola P, Stolen KQ, Hannukainen J, Nuutila P, Laakso M, Knuuti J.
    J Nucl Cardiol; 2007 Jul 26; 14(3):354-65. PubMed ID: 17556170
    [Abstract] [Full Text] [Related]

  • 56. Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection.
    Ebert A, Herzog H, Stöcklin GL, Henrich MM, DeGrado TR, Coenen HH, Feinendegen LE.
    J Nucl Med; 1994 Jan 26; 35(1):51-6. PubMed ID: 8271060
    [Abstract] [Full Text] [Related]

  • 57. Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes.
    Burgeiro A, Fuhrmann A, Cherian S, Espinoza D, Jarak I, Carvalho RA, Loureiro M, Patrício M, Antunes M, Carvalho E.
    Am J Physiol Endocrinol Metab; 2016 Apr 01; 310(7):E550-64. PubMed ID: 26814014
    [Abstract] [Full Text] [Related]

  • 58. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM.
    Am J Physiol Endocrinol Metab; 2008 Feb 01; 294(2):E357-64. PubMed ID: 18042664
    [Abstract] [Full Text] [Related]

  • 59. Myocardial mechanical dysfunction following endotoxemia: role of changes in energy substrate metabolism.
    Soraya H, Masoud WG, Gandhi M, Garjani A, Clanachan AS.
    Basic Res Cardiol; 2016 Mar 01; 111(2):24. PubMed ID: 26926341
    [Abstract] [Full Text] [Related]

  • 60. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, Juhani Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J.
    Circulation; 2008 Sep 16; 118(12):1250-8. PubMed ID: 18765391
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.